Wells Fargo & Company Senseonics Holdings, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 96,326 shares of SENS stock, worth $32,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,326
Previous 471,942
79.59%
Holding current value
$32,750
Previous $250,000
84.8%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding SENS
# of Institutions
141Shares Held
59.8MCall Options Held
413KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA23.2MShares$7.88 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.32MShares$2.83 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA7MShares$2.38 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA5.66MShares$1.92 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.11MShares$1.06 Million0.0% of portfolio
About Senseonics Holdings, Inc.
- Ticker SENS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 465,447,008
- Market Cap $158M
- Description
- Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...